Studies
A phase 0 first-in-human clinical trial of [203Pb]VMT-α-NET SPECT/CT for somatostatin receptor imaging of neuroendocrine tumors
Cancer
Radiology
Neuroendocrine Tumors
Adult Subjects
Female Subjects
Male Subjects
This is a first in man study to determine if [203Pb]VMT-α-NET identifies neuroendocrine tumors with SPECT/CT. This is the first step to testing [212Pb]-based alpha radiation therapy in neuroendocrine therapy.